Vaccine development refers to the process of researching, creating, and bringing a vaccine to market to prevent infectious diseases. This process typically involves several stages, including:
1. **Exploratory Research**: Scientists study the pathogen that causes the disease to identify potential targets for the vaccine.
2. **Preclinical Testing**: Laboratory and animal studies are conducted to evaluate the safety and immune response generated by the vaccine candidates.
3. **Clinical Trials**: The vaccine undergoes several phases of clinical testing in humans, typically divided into three phases:
– Phase 1: Small groups of healthy volunteers are tested for safety and immune response.
– Phase 2: Larger groups receive the vaccine to further assess safety, dosing, and immune response.
– Phase 3: The vaccine is given to thousands of participants to evaluate its efficacy and safety in a broader population.
4. **Regulatory Review**: After successful trials, the vaccine manufacturer submits data to regulatory authorities for approval.
5. **Production**: Once approved, the vaccine enters mass production to ensure adequate supply.
6. **Post-Marketing Surveillance**: After the vaccine is released, ongoing monitoring for safety and effectiveness occurs.
Vaccine development is essential for controlling infectious diseases and is a critical component of public health.
BioNTech is shifting focus from its COVID-19 vaccine success to mRNA-based cancer therapies, aiming for market approvals by 2026. The fourth quarter of 2024 saw BioNTech's earnings and revenue decline,…